Magazine Article | May 2, 2018

Best Practices To Prevent Clinical Trial Protocol Deviations

Source: Life Science Leader

By Laurie Halloran

Protocols serve to protect the people who participate in clinical trials and provide standards so the data collected supports the study’s objectives. When protocols are not followed, it can create serious issues that slow down the study or significantly increase costs. These best practices can help sponsors and CROs work together seamlessly to prevent and alleviate protocol deviations in their clinical studies, keeping development on time and within budget.

The guideline for Good Clinical Practice of the International Council on Harmonization (ICH GCP) defines the protocol as “A document that describes the objective(s), design, methodology, statistical considerations, and organization of a trial.” Protocols should be written in a clear and concise manner to provide all study personnel with a comprehensive understanding of the disease, the study’s population, and the investigational agent. Consideration must also be given to the burden that will be placed on subjects to participate and investigators to administer with integrity and rigor.

VIEW THE MAGAZINE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader